Task: Answer the MCQ question.
Question: Which drug exhibits a -54.137% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1c(CC(=O)N[C@@H](CCCNC(N)=O)C(=O)O)c(=O)oc2cc3oc4c(c3cc12)CCCC4
b) Cc1cccc2sc(N(CCCN(C)C)C(=O)CCc3ccccc3)nc12.Cl
Answer: b. Cc1cccc2sc(N(CCCN(C)C)C(=O)CCc3ccccc3)nc12.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc2sc(N(CCCN(C)C)C(=O)CCc3ccccc3)nc12.Cl
Cc1cccc2sc(N(CCCN(C)C)C(=O)CCc3ccccc3)nc12.Cl
N-[3-(dimethylamino)propyl]-N-(4-methyl-1,3-benzothiazol-2-yl)-3-phenylpropanamide;hydrochloride